AERIE PHARMACEUTICALS INC's ticker is AERI and the CUSIP is 00771V108. A total of 151 filers reported holding AERIE PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is 0.43 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $2,298,000 | +172.9% | 201,601 | +283.1% | 0.00% | – |
| Q2 2021 | $842,000 | -80.8% | 52,620 | -78.5% | 0.00% | -100.0% |
| Q1 2021 | $4,382,000 | +32.4% | 245,226 | +0.1% | 0.00% | 0.0% |
| Q4 2020 | $3,310,000 | -17.7% | 244,976 | -28.3% | 0.00% | 0.0% |
| Q3 2020 | $4,022,000 | -31.8% | 341,722 | -14.5% | 0.00% | -50.0% |
| Q2 2020 | $5,900,000 | +4.0% | 399,753 | -4.9% | 0.00% | 0.0% |
| Q1 2020 | $5,673,000 | -44.1% | 420,188 | 0.0% | 0.00% | -33.3% |
| Q4 2019 | $10,156,000 | +25.8% | 420,188 | 0.0% | 0.00% | +50.0% |
| Q3 2019 | $8,076,000 | -29.9% | 420,188 | +7.8% | 0.00% | -50.0% |
| Q2 2019 | $11,519,000 | -30.1% | 389,821 | +12.3% | 0.00% | -20.0% |
| Q1 2019 | $16,486,000 | +52.4% | 347,056 | +15.8% | 0.01% | +25.0% |
| Q4 2018 | $10,815,000 | -41.4% | 299,593 | 0.0% | 0.00% | -33.3% |
| Q3 2018 | $18,440,000 | -8.9% | 299,593 | 0.0% | 0.01% | -14.3% |
| Q2 2018 | $20,237,000 | +24.5% | 299,593 | 0.0% | 0.01% | +16.7% |
| Q1 2018 | $16,253,000 | +5.5% | 299,593 | +16.2% | 0.01% | 0.0% |
| Q4 2017 | $15,405,000 | +22.9% | 257,834 | 0.0% | 0.01% | +20.0% |
| Q3 2017 | $12,531,000 | – | 257,834 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JACOB ASSET MANAGEMENT OF NEW YORK LLC | 244,783 | $1,718,000 | 0.77% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 4,695,020 | $32,959,000 | 0.69% |
| DCF Advisers, LLC | 192,065 | $1,348,000 | 0.55% |
| LEVIN CAPITAL STRATEGIES, L.P. | 817,377 | $5,738,000 | 0.54% |
| DAFNA Capital Management LLC | 289,040 | $2,029,000 | 0.51% |
| Rhenman & Partners Asset Management AB | 750,000 | $5,378,000 | 0.36% |
| NEXPOINT ASSET MANAGEMENT, L.P. | 309,778 | $2,175,000 | 0.31% |
| RICE HALL JAMES & ASSOCIATES, LLC | 1,203,592 | $8,449,000 | 0.30% |
| AlphaCentric Advisors LLC | 137,000 | $962,000 | 0.28% |
| PFM Health Sciences, LP | 1,088,566 | $7,642,000 | 0.26% |